These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22640805)

  • 21. Distinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissues.
    Zhao H; Ramos CF; Brooks JD; Peehl DM
    J Cell Physiol; 2007 Jan; 210(1):111-21. PubMed ID: 17044071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer.
    Zhang X; Wang Y; Ning Y
    Urol Oncol; 2017 Mar; 35(3):111.e15-111.e23. PubMed ID: 27856181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Candidate diagnostic miRNAs that can detect cancer in prostate biopsy.
    Paziewska A; Mikula M; Dabrowska M; Kulecka M; Goryca K; Antoniewicz A; Dobruch J; Borowka A; Rutkowski P; Ostrowski J
    Prostate; 2018 Feb; 78(3):178-185. PubMed ID: 29226351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stromal Gene Expression is Predictive for Metastatic Primary Prostate Cancer.
    Mo F; Lin D; Takhar M; Ramnarine VR; Dong X; Bell RH; Volik SV; Wang K; Xue H; Wang Y; Haegert A; Anderson S; Brahmbhatt S; Erho N; Wang X; Gout PW; Morris J; Karnes RJ; Den RB; Klein EA; Schaeffer EM; Ross A; Ren S; Sahinalp SC; Li Y; Xu X; Wang J; Wang J; Gleave ME; Davicioni E; Sun Y; Wang Y; Collins CC
    Eur Urol; 2018 Apr; 73(4):524-532. PubMed ID: 28330676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrated analysis of the prostate cancer small-nucleolar transcriptome reveals SNORA55 as a driver of prostate cancer progression.
    Crea F; Quagliata L; Michael A; Liu HH; Frumento P; Azad AA; Xue H; Pikor L; Watahiki A; Morant R; Eppenberger-Castori S; Wang Y; Parolia A; Lennox KA; Lam WL; Gleave M; Chi KN; Pandha H; Wang Y; Helgason CD
    Mol Oncol; 2016 May; 10(5):693-703. PubMed ID: 26809501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genes upregulated in prostate cancer reactive stroma promote prostate cancer progression in vivo.
    Dakhova O; Rowley D; Ittmann M
    Clin Cancer Res; 2014 Jan; 20(1):100-9. PubMed ID: 24150235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Global gene expression analysis of reactive stroma in prostate cancer.
    Dakhova O; Ozen M; Creighton CJ; Li R; Ayala G; Rowley D; Ittmann M
    Clin Cancer Res; 2009 Jun; 15(12):3979-89. PubMed ID: 19509179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Up-regulated expression of the MAT-8 gene in prostate cancer and its siRNA-mediated inhibition of expression induces a decrease in proliferation of human prostate carcinoma cells.
    Grzmil M; Voigt S; Thelen P; Hemmerlein B; Helmke K; Burfeind P
    Int J Oncol; 2004 Jan; 24(1):97-105. PubMed ID: 14654946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of two gene panels for prostate cancer diagnosis and patient risk stratification.
    Xiao K; Guo J; Zhang X; Feng X; Zhang H; Cheng Z; Johnson H; Persson JL; Chen L
    Tumour Biol; 2016 Aug; 37(8):10115-22. PubMed ID: 26820133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated AKR1C3 expression promotes prostate cancer cell survival and prostate cell-mediated endothelial cell tube formation: implications for prostate cancer progression.
    Dozmorov MG; Azzarello JT; Wren JD; Fung KM; Yang Q; Davis JS; Hurst RE; Culkin DJ; Penning TM; Lin HK
    BMC Cancer; 2010 Dec; 10():672. PubMed ID: 21134280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential expression of peroxiredoxins in prostate cancer: consistent upregulation of PRDX3 and PRDX4.
    Basu A; Banerjee H; Rojas H; Martinez SR; Roy S; Jia Z; Lilly MB; De León M; Casiano CA
    Prostate; 2011 May; 71(7):755-65. PubMed ID: 21031435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer.
    Rubin MA; Zhou M; Dhanasekaran SM; Varambally S; Barrette TR; Sanda MG; Pienta KJ; Ghosh D; Chinnaiyan AM
    JAMA; 2002 Apr; 287(13):1662-70. PubMed ID: 11926890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Profiling of differential expression of messenger RNA in normal, benign, and metastatic prostate cell lines.
    Chakrabarti R; Robles LD; Gibson J; Muroski M
    Cancer Genet Cytogenet; 2002 Dec; 139(2):115-25. PubMed ID: 12550771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. WDR19 expression is increased in prostate cancer compared with normal cells, but low-intensity expression in cancers is associated with shorter time to biochemical failures and local recurrence.
    Lin B; Utleg AG; Gravdal K; White JT; Halvorsen OJ; Lu W; True LD; Vessella R; Lange PH; Nelson PS; Hood L; Kalland KH; Akslen LA
    Clin Cancer Res; 2008 Mar; 14(5):1397-406. PubMed ID: 18316561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1.
    Lin ZY; Huang YQ; Zhang YQ; Han ZD; He HC; Ling XH; Fu X; Dai QS; Cai C; Chen JH; Liang YX; Jiang FN; Zhong WD; Wang F; Wu CL
    Int J Cancer; 2014 Aug; 135(3):541-50. PubMed ID: 24382668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a predictive model for stromal content in prostate cancer samples to improve signature performance.
    Boufaied N; Takhar M; Nash C; Erho N; Bismar TA; Davicioni E; Thomson AA
    J Pathol; 2019 Dec; 249(4):411-424. PubMed ID: 31206668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening and identification of significant genes related to tumor metastasis and PSMA in prostate cancer using microarray analysis.
    Xu L; Wang Z; Li XF; He X; Guan LL; Tuo JL; Wang Y; Luo Y; Zhong HL; Qiu SP; Cao KY
    Oncol Rep; 2013 Oct; 30(4):1920-8. PubMed ID: 23917490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors.
    Calvo A; Xiao N; Kang J; Best CJ; Leiva I; Emmert-Buck MR; Jorcyk C; Green JE
    Cancer Res; 2002 Sep; 62(18):5325-35. PubMed ID: 12235003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Steroidogenic enzymes and stem cell markers are upregulated during androgen deprivation in prostate cancer.
    Pfeiffer MJ; Smit FP; Sedelaar JP; Schalken JA
    Mol Med; 2011; 17(7-8):657-64. PubMed ID: 21365123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression patterns of candidate susceptibility genes HNF1β and CtBP2 in prostate cancer: association with tumor progression.
    Debiais-Delpech C; Godet J; Pedretti N; Bernard FX; Irani J; Cathelineau X; Cussenot O; Fromont G
    Urol Oncol; 2014 May; 32(4):426-32. PubMed ID: 24332637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.